Cell Biotech acquire a European patent for anticancer protein P8 originated from Lactobacillus rhamnosus

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 04/06/2021.
  • Additional Information
    • Alternate Title:
      CELL-BIOTECH-patent
    • Subject Terms:
      South Korea; Europe
    • Abstract:
      SEOUL, South Korea, April 6, 2021 /PRNewswire/ -- Cell Biotech (KRX 049960), a probiotics & microbiome company, has acquired a European patent (Registration No. EP3453718) for the anticancer protein P8 originated from Lactobacillus rhamnosus for the new colorectal cancer drug "PP-P8". [ABSTRACT FROM PUBLISHER]